The biological role of the Fas/FasL system during tumor formation and progression

被引:117
作者
Reichmann, E [1 ]
机构
[1] Univ Zurich, Childrens Hosp, Dept Pediat Surg, Fetal & Pediat Surg Res Lab, CH-8032 Zurich, Switzerland
关键词
apoptosis; Fas; Fas-ligand; tissue homeostasis; tumor development; anti-cancer therapy;
D O I
10.1016/S1044-579X(02)00017-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cells of an organism are constantly exposed to conflicting environmental cues that signal cell survival or cell death. Survival signals are delivered by autocrine or paracrine factors that actively suppress a default death pathway. This default death pathway appears to be activated by dedicated death receptors such as Fas, the TRAIL-receptors and other tumor necrosis factor receptor superfamily proteins (TNFR SFPs). Our understanding of how these counteracting receptor systems are modulated during tumorigenesis is only moderate. Nevertheless, there is now broad evidence that susceptibility of tumor cells towards Fas-mediated apoptosis is largely reduced. In addition, tumor cells frequently exhibit de novo expression of Fas-ligand (FasL) which plays a significant role in local tissue destruction, metastatic spread and immune escape of the tumor cells. Restoring the apoptotic potential of cancer cells upon modulating the expression and activity of certain key components of the cell death machinery is an attractive and obvious therapeutic anti-cancer strategy.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 61 条
[11]  
Hsu SC, 1999, EUR J IMMUNOL, V29, P2948, DOI 10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO
[12]  
2-0
[13]   Inhibition of death receptor signals by cellular FLIP [J].
Irmler, M ;
Thome, M ;
Hahne, M ;
Schneider, P ;
Hofmann, B ;
Steiner, V ;
Bodmer, JL ;
Schroter, M ;
Burns, K ;
Mattmann, C ;
Rimoldi, D ;
French, LE ;
Tschopp, J .
NATURE, 1997, 388 (6638) :190-195
[14]   THE POLYPEPTIDE ENCODED BY THE CDNA FOR HUMAN CELL-SURFACE ANTIGEN FAS CAN MEDIATE APOPTOSIS [J].
ITOH, N ;
YONEHARA, S ;
ISHII, A ;
YONEHARA, M ;
MIZUSHIMA, S ;
SAMESHIMA, M ;
HASE, A ;
SETO, Y ;
NAGATA, S .
CELL, 1991, 66 (02) :233-243
[15]  
JAATTELA M, 1995, ONCOGENE, V10, P2297
[16]   Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand [J].
Jo, M ;
Kim, TH ;
Seol, DW ;
Esplen, JE ;
Dorko, K ;
Billiar, TR ;
Strom, SC .
NATURE MEDICINE, 2000, 6 (05) :564-567
[17]   DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-KB and AP-1 [J].
Kasibhatla, S ;
Brunner, T ;
Genestier, L ;
Echeverri, F ;
Mahboubi, A ;
Green, DR .
MOLECULAR CELL, 1998, 1 (04) :543-551
[18]  
Kataoka T, 1998, J IMMUNOL, V161, P3936
[19]   METALLOPROTEINASE-MEDIATED RELEASE OF HUMAN FAS LIGAND [J].
KAYAGAKI, N ;
KAWASAKI, A ;
EBATA, T ;
OHMOTO, H ;
IKEDA, S ;
INOUE, S ;
YOSHINO, K ;
OKUMURA, K ;
YAGITA, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1777-1783
[20]  
Keane MM, 1996, CANCER RES, V56, P4791